Considerations for Technology Companies Managing Section 409A Risk and Equity-Based Compensation
The technology sector is booming—fueled by rapid expansion in generative AI, cloud platforms, SaaS solutions, and venture-backed innovation. In San Diego, this growth intersects with the region’s globally recognized biotech ecosystem, home to hundreds of research-driven companies that rely on advanced data tools, AI discovery platforms, and a highly specialized workforce. From early-stage biotech startups to publicly traded life sciences firms, companies in the region use equity-based compensation (e.g., stock options, restricted stock units (RSUs)) and nonqualified deferred compensation (NQDC) to attract and retain top scientific and executive talent. However, without careful legal structuring and administration, these arrangements can easily run afoul of Section 409A of the Internal Revenue Code (IRC), triggering steep tax penalties and administrative exposure.
